acetylcysteine has been researched along with Aortic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakoyiannis, C; Iliopoulos, D; Kapelouzou, A; Liakakos, T; Mastrogeorgiou, M; Mylonas, KS; Nikiteas, N; Schizas, D; Spartalis, E; Spartalis, M | 1 |
| Asanuma, K; Galis, ZS; Godin, D; Meng, X | 1 |
2 other study(ies) available for acetylcysteine and Aortic Diseases
| Article | Year |
|---|---|
KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Colchicine; Disease Models, Animal; Drug Therapy, Combination; Fibric Acids; Hyperlipidemias; Kruppel-Like Factor 4; Male; Plaque, Atherosclerotic; Rabbits; Up-Regulation | 2022 |
N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?
Topics: Acetylcysteine; Animals; Aortic Diseases; Arteriosclerosis; Collagenases; Foam Cells; Free Radical Scavengers; Gelatinases; Hypercholesterolemia; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Rabbits | 1998 |